Insider Transactions in Q1 2022 at Outset Medical, Inc. (OM)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 24
2022
|
Nabeel Ahmed Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
424
-0.94%
|
$17,808
$42.65 P/Share
|
|
Mar 17
2022
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
1,400
-3.95%
|
$56,000
$40.46 P/Share
|
|
Mar 16
2022
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
1,392
-3.78%
|
$54,288
$39.77 P/Share
|
|
Mar 16
2022
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
3,631
-1.17%
|
$141,609
$39.77 P/Share
|
|
Mar 16
2022
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,030
-2.04%
|
$40,170
$39.77 P/Share
|
|
Mar 15
2022
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
6,586
-7.91%
|
$250,268
$38.59 P/Share
|
|
Mar 15
2022
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,586
+7.11%
|
$59,274
$9.48 P/Share
|
|
Mar 09
2022
|
Stacey L. Porter Chief People Officer |
SELL
Open market or private sale
|
Direct |
416
-1.33%
|
$17,056
$41.72 P/Share
|
|
Mar 09
2022
|
Nabeel Ahmed Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
477
-1.05%
|
$19,557
$41.72 P/Share
|
|
Mar 01
2022
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-9.01%
|
$215,000
$43.51 P/Share
|
|
Mar 01
2022
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.26%
|
$40,000
$8.62 P/Share
|
|
Mar 01
2022
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
1,003
-2.65%
|
$43,129
$43.73 P/Share
|
|
Mar 01
2022
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
20,000
-6.03%
|
$860,000
$43.49 P/Share
|
|
Mar 01
2022
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+5.69%
|
$60,000
$3.88 P/Share
|
|
Feb 15
2022
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
10,002
-11.62%
|
$350,070
$35.92 P/Share
|
|
Feb 15
2022
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
10,002
+10.29%
|
$90,018
$9.48 P/Share
|
|
Feb 02
2022
|
Leslie Trigg Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
11,706
+3.63%
|
-
|
|
Feb 01
2022
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
20,000
-6.26%
|
$740,000
$37.5 P/Share
|
|
Feb 01
2022
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+5.89%
|
$60,000
$3.88 P/Share
|
|
Feb 01
2022
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-9.01%
|
$185,000
$37.44 P/Share
|
|
Feb 01
2022
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.26%
|
$40,000
$8.62 P/Share
|
|
Jan 26
2022
|
Leslie Trigg Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
48,840
+14.02%
|
-
|
|
Jan 26
2022
|
John L. Brottem General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
24,762
+21.43%
|
-
|
|
Jan 26
2022
|
Jean Olivier Racine Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,698
+18.78%
|
-
|
|
Jan 26
2022
|
Stacey L. Porter Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,539
+19.33%
|
-
|
|
Jan 26
2022
|
Nabeel Ahmed Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,888
+20.97%
|
-
|
|
Jan 26
2022
|
Martin Vazquez Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,270
+24.44%
|
-
|
|
Jan 26
2022
|
Steven S. Williamson Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,888
+16.26%
|
-
|
|
Jan 25
2022
|
Steven S. Williamson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,280
-5.98%
|
$84,360
$37.74 P/Share
|
|
Jan 21
2022
|
Steven S. Williamson Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,205
+19.44%
|
-
|
|
Jan 18
2022
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
10,002
-27.56%
|
$350,070
$35.61 P/Share
|
|
Jan 18
2022
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
10,002
+21.27%
|
$90,018
$9.48 P/Share
|
|
Jan 03
2022
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
16,000
-23.48%
|
$752,000
$47.05 P/Share
|
|
Jan 03
2022
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+18.05%
|
$64,000
$4.02 P/Share
|
|
Jan 03
2022
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
2,500
-16.61%
|
$117,500
$47.05 P/Share
|
|
Jan 03
2022
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
42,500
-5.33%
|
$1,997,500
$47.1 P/Share
|
|
Jan 03
2022
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
42,500
+5.04%
|
$127,500
$3.88 P/Share
|